BioCryst Pharmaceuticals, Inc. (BCRX)
BCRX Stock Chart More Charts
BCRX Price/Volume Stats
| Current price | $5.06 |
| Prev. close | $5.14 |
| Day low | $4.93 |
| Day high | $5.14 |
| 50-day MA | $5.05 |
| 200-day MA | $5.02 |
| 52-week high | $7.39 |
| 52-week low | $3.95 |
| Volume | 79,724 |
| Avg. volume | 1,130,313 |
| Dividend yield | N/A |
| Market Cap | 499.42M |
BCRX Returns
| 1-mo | 0.40% |
| 3-mo | -9.48% |
| 6-mo | 5.42% |
| 1-year | -23.56% |
| 3-year | -50.83% |
| 5-year | 179.56% |
| YTD | 3.05% |
| 2017 | -22.43% |
| 2016 | -38.66% |
| 2015 | -15.13% |
| 2014 | 60.00% |
| 2013 | 435.21% |
BioCryst Pharmaceuticals, Inc. (BCRX) Company Bio
Biocryst Pharmaceuticals designs, optimizes and develops novel small molecule drugs that block key enzymes involved in rare diseases. The company was founded in 1986 and is based in Durham, North Carolina.
Loading social stream, please wait...